MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202647096531 A) filed by Systimmune, Inc. on August 10, 2026, for Antibody-Auristatin Drug Conjugate And Pharmaceutical Use Thereof.
Inventors include Zhu, Yi; Wan, Weili; Zhuo, Shi; Lai, Weirong Number; and Zhang, Yong.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: The application provides, among others, antibody-drug conjugates formed from a bispecific antibody and an auristatin drug unit, or a pharmaceutically acceptable salt or solvate thereof, and methods of making and using thereof. The application further provides linker-drug compounds, their isomers, endo-, racemates, enantiomers, or mixtures thereof, or pharmaceutically acceptable salts or solvates thereof, and methods of making and using thereof.
Disclaimer: Curated by HT Syndication.
